ALLO
Price
$1.18
Change
-$0.03 (-2.50%)
Updated
May 8, 04:59 PM (EDT)
Capitalization
258.07M
4 days until earnings call
BEAM
Price
$17.21
Change
+$0.98 (+6.04%)
Updated
May 8, 04:59 PM (EDT)
Capitalization
1.63B
95 days until earnings call
Ad is loading...

ALLO vs BEAM

Header iconALLO vs BEAM Comparison
Open Charts ALLO vs BEAMBanner chart's image
Allogene Therapeutics
Price$1.18
Change-$0.03 (-2.50%)
Volume$43.77K
Capitalization258.07M
Beam Therapeutics
Price$17.21
Change+$0.98 (+6.04%)
Volume$51.12K
Capitalization1.63B
ALLO vs BEAM Comparison Chart
Loading...
ALLO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALLO vs. BEAM commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALLO is a Hold and BEAM is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
May 09, 2025
Stock price -- (ALLO: $1.18 vs. BEAM: $17.25)
Brand notoriety: ALLO and BEAM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALLO: 234% vs. BEAM: 119%
Market capitalization -- ALLO: $258.07M vs. BEAM: $1.63B
ALLO [@Biotechnology] is valued at $258.07M. BEAM’s [@Biotechnology] market capitalization is $1.63B. The market cap for tickers in the [@Biotechnology] industry ranges from $301.75B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALLO’s FA Score shows that 0 FA rating(s) are green whileBEAM’s FA Score has 0 green FA rating(s).

  • ALLO’s FA Score: 0 green, 5 red.
  • BEAM’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than ALLO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALLO’s TA Score shows that 4 TA indicator(s) are bullish while BEAM’s TA Score has 5 bullish TA indicator(s).

  • ALLO’s TA Score: 4 bullish, 5 bearish.
  • BEAM’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than ALLO.

Price Growth

ALLO (@Biotechnology) experienced а -30.18% price change this week, while BEAM (@Biotechnology) price change was -13.01% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.65%. For the same industry, the average monthly price growth was +15.24%, and the average quarterly price growth was -12.41%.

Reported Earning Dates

ALLO is expected to report earnings on Aug 06, 2025.

BEAM is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (-3.65% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($1.63B) has a higher market cap than ALLO($258M). BEAM YTD gains are higher at: -30.444 vs. ALLO (-44.601). ALLO has higher annual earnings (EBITDA): -243.33M vs. BEAM (-383.98M). BEAM has more cash in the bank: 851M vs. ALLO (292M). ALLO has less debt than BEAM: ALLO (90.8M) vs BEAM (161M). BEAM has higher revenues than ALLO: BEAM (63.5M) vs ALLO (22K).
ALLOBEAMALLO / BEAM
Capitalization258M1.63B16%
EBITDA-243.33M-383.98M63%
Gain YTD-44.601-30.444147%
P/E RatioN/AN/A-
Revenue22K63.5M0%
Total Cash292M851M34%
Total Debt90.8M161M56%
FUNDAMENTALS RATINGS
ALLO: Fundamental Ratings
ALLO
OUTLOOK RATING
1..100
5
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
90
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALLOBEAM
RSI
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 7 days ago
80%
Bullish Trend 15 days ago
79%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 3 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
78%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Ad is loading...
ALLO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IVOIX17.720.15
+0.85%
Macquarie Mid Cap Income Opps I
JORCX17.020.06
+0.35%
Janus Henderson Global Select C
AULRX73.52N/A
N/A
American Century Ultra® R
MOJCX13.02N/A
N/A
Donoghue Forlines Momentum C
JERNX11.69-0.09
-0.76%
Janus Henderson Global Real Estate N